Locus Biosciences
id:
locus-biosciences-281-11582293
title:
Locus Biosciences
text:
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. The intended therapeutic targets are antibiotic-resistant bacterial infections.
brand slug:
wiki
category slug:
encyclopedia
description:
Clinical phase American pharmaceutical company
original url:
https://en.wikipedia.org/wiki/Locus_Biosciences
date created:
date modified:
2024-02-28T10:30:50Z
main entity:
{"identifier":"Q65081117","url":"https://www.wikidata.org/entity/Q65081117"}
image:
fields total:
13
integrity:
14